Ligand Pharmaceuticals | Resultado Líquido



Net Income Alterar Data
Amgen USD 627M 2.2B 2024-12
Arrowhead Research USD -173085000 2.55M 2024-12
Baxter International USD -512000000 652M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 414M 472M 2024-12
Glaxosmithkline GBP 414M 472M 2024-12
Insmed USD -235548000 15.02M 2024-12
Ionis Pharmaceuticals USD -104349000 36.13M 2024-12
Ligand Pharmaceuticals USD -31088000 23.92M 2024-12
MacroGenics USD -15421000 71.73M 2024-12
Merck USD 3.74B 586M 2024-12
Pacira USD 16.04M 159.51M 2024-12
Pfizer USD 410M 4.06B 2024-12
Veracyte USD 5.11M 10.04M 2024-12



Ligand Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.